These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
628 related items for PubMed ID: 30254642
41. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription. Le Borgne S, Février M, Callebaut C, Lee SP, Rivière Y. J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581 [Abstract] [Full Text] [Related]
42. HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients. Li W, Li C, Xia W, Li X. Hum Vaccin Immunother; 2017 Oct 03; 13(10):2341-2347. PubMed ID: 28771107 [Abstract] [Full Text] [Related]
43. HIV-1 Nef sequence and functional compartmentalization in the gut is not due to differential cytotoxic T lymphocyte selective pressure. Lewis MJ, Frohnen P, Ibarrondo FJ, Reed D, Iyer V, Ng HL, Elliott J, Yang OO, Anton P. PLoS One; 2013 Oct 03; 8(9):e75620. PubMed ID: 24058696 [Abstract] [Full Text] [Related]
44. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection. Amu S, Lantto Graham R, Bekele Y, Nasi A, Bengtsson C, Rethi B, Sorial S, Meini G, Zazzi M, Hejdeman B, Chiodi F. Medicine (Baltimore); 2016 Jun 03; 95(23):e3738. PubMed ID: 27281071 [Abstract] [Full Text] [Related]
49. Impact of antiretroviral and tuberculosis therapies on CD4+ and CD8+ HIV/M. tuberculosis-specific T-cell in co-infected subjects. Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, La Manna MP, Orlando V, Pinnetti C, Sampaolesi A, Antinori A, Caccamo N, Goletti D. Immunol Lett; 2018 Jun 15; 198():33-43. PubMed ID: 29635002 [Abstract] [Full Text] [Related]
51. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. Grau-Expósito J, Serra-Peinado C, Miguel L, Navarro J, Curran A, Burgos J, Ocaña I, Ribera E, Torrella A, Planas B, Badía R, Castellví J, Falcó V, Crespo M, Buzon MJ. mBio; 2017 Jul 11; 8(4):. PubMed ID: 28698276 [Abstract] [Full Text] [Related]
52. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection. Eller MA, Eller LA, Ratto-Kim S, Ouma BJ, Lo V, de Souza M, Guwatudde D, Nails B, Michael NL, Wabwire-Mangen F, Robb ML, Marovich MA, Sandberg JK, Currier JR. J Acquir Immune Defic Syndr; 2012 Sep 01; 61(1):9-18. PubMed ID: 22580564 [Abstract] [Full Text] [Related]
53. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. J Virol; 2015 May 01; 89(10):5687-700. PubMed ID: 25822027 [Abstract] [Full Text] [Related]
60. α4β7+ CD4+ Effector/Effector Memory T Cells Differentiate into Productively and Latently Infected Central Memory T Cells by Transforming Growth Factor β1 during HIV-1 Infection. Cheung KW, Wu T, Ho SF, Wong YC, Liu L, Wang H, Chen Z. J Virol; 2018 Apr 15; 92(8):. PubMed ID: 29386290 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]